Avadel Pharma (AVDL) Misses Q1 EPS by 7c

Avadel Pharma (NASDAQ: AVDL) reported Q1 EPS of ($0.30), $0.07 worse than the analyst estimate of ($0.23). Revenue for the quarter came in at $27.18 million versus the consensus estimate of $26.17 million.

For earnings history and earnings-related data on Avadel Pharma (AVDL) click here.

You May Also Be Interested In

• Mizuho says ignore Apple noise, flags key catalyst for Micron and memory in H2
• MediaTek Inc. (2454:TT) (MDTKF) PT Raised to NT$5,800 at Nomura/Instinet
• Zhen Ding Technology Holding Limited (4958:TT) (HASGF) PT Raised to NT$720 at Nomura/Instinet